We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 10.82%
3 Consumer Discretionary 10.62%
4 Healthcare 9.9%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYFM icon
2226
Hydrofarm Holdings
HYFM
$7M
$46K ﹤0.01%
78
IDYA icon
2227
IDEAYA Biosciences
IDYA
$3.49B
$46K ﹤0.01%
2,201
+744
+51% +$15.3K
KE
2228
Kimball Electronics
KE
$622M
$46K ﹤0.01%
2,097
KROS icon
2229
Keros Therapeutics
KROS
$200M
$46K ﹤0.01%
1,092
MSBI icon
2230
Midland States Bancorp
MSBI
$693M
$46K ﹤0.01%
1,739
PDFS icon
2231
PDF Solutions
PDFS
$2.15B
$46K ﹤0.01%
2,532
PSR icon
2232
Invesco Active US Real Estate Fund
PSR
$60.1M
$46K ﹤0.01%
445
TLS icon
2233
Telos
TLS
$339M
$46K ﹤0.01%
1,341
TPB icon
2234
Turning Point Brands
TPB
$1.75B
$46K ﹤0.01%
1,011
BCOV
2235
DELISTED
Brightcove, Inc.
BCOV
$46K ﹤0.01%
3,175
ICPT
2236
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$46K ﹤0.01%
2,290
SPPI
2237
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$46K ﹤0.01%
12,291
CLVS
2238
DELISTED
Clovis Oncology, Inc.
CLVS
$46K ﹤0.01%
7,887
+1,500
+23% +$8.79K
XENT
2239
DELISTED
Intersect ENT, Inc
XENT
$46K ﹤0.01%
2,690
PAE
2240
DELISTED
PAE Incorporated Class A Common Stock
PAE
$46K ﹤0.01%
5,218
BY icon
2241
Byline Bancorp
BY
$1.78B
$45K ﹤0.01%
1,998
RAPT
2242
DELISTED
RAPT Therapeutics
RAPT
$45K ﹤0.01%
176
+55
+45% +$10.3K
RBBN icon
2243
Ribbon Communications
RBBN
$377M
$45K ﹤0.01%
5,864
TALO icon
2244
Talos Energy
TALO
$2.63B
$45K ﹤0.01%
2,891
+1,848
+177% +$25.5K
THR
2245
DELISTED
Thermon Group Holdings
THR
$45K ﹤0.01%
2,669
CNR
2246
Core Natural Resources Inc
CNR
$4.76B
$45K ﹤0.01%
2,417
ACEL icon
2247
Accel Entertainment
ACEL
$1.01B
$44K ﹤0.01%
3,729
AKBA icon
2248
Akebia Therapeutics
AKBA
$242M
$44K ﹤0.01%
11,500
AMRX icon
2249
Amneal Pharmaceuticals
AMRX
$6.32B
$44K ﹤0.01%
8,537
ATNI icon
2250
ATN International
ATNI
$488M
$44K ﹤0.01%
967

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.